ACTL6A and cholangiocarcinoma: This finding provides direct evidence for understanding the dual roles of ACTL6A (signaling pathway regulation and chromatin remodeling) in CCA malignant progression and suggests that targeting the ACTL6A-LINC00313 interaction may represent a novel strategy to interfere with Wnt/TGFβ crosstalk.